FIBP
Basic information
Region (hg38): 11:65883740-65888531
Links
Phenotypes
GenCC
Source:
- tall stature-intellectual disability-renal anomalies syndrome (Supportive), mode of inheritance: AR
- tall stature-intellectual disability-renal anomalies syndrome (Strong), mode of inheritance: AR
- tall stature-intellectual disability-renal anomalies syndrome (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Thauvin-Robinet-Faivre syndrome | AR | Cardiovascular; Oncologic | The condition may include increased risk of Wilms tumor, and awareness may allow surveillance, early diagnosis, and management; The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic; Renal | 26660953; 27183861 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (50 variants)
- not_provided (19 variants)
- Tall_stature-intellectual_disability-renal_anomalies_syndrome (10 variants)
- FIBP-related_disorder (5 variants)
- Large_hands (1 variants)
- Congenital_ocular_coloboma (1 variants)
- Overgrowth (1 variants)
- Congenital_anomaly_of_face (1 variants)
- Macrocephaly (1 variants)
- Learning_disability (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FIBP gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004214.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 12 | 15 | ||||
| missense | 52 | 54 | ||||
| nonsense | 3 | |||||
| start loss | 0 | |||||
| frameshift | 3 | |||||
| splice donor/acceptor (+/-2bp) | 3 | |||||
| Total | 0 | 4 | 57 | 13 | 4 |
Highest pathogenic variant AF is 0.000003340694
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| FIBP | protein_coding | protein_coding | ENST00000338369 | 10 | 4799 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00000439 | 0.852 | 125726 | 0 | 22 | 125748 | 0.0000875 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.03 | 181 | 224 | 0.807 | 0.0000132 | 2380 |
| Missense in Polyphen | 45 | 73.37 | 0.61333 | 858 | ||
| Synonymous | -0.912 | 103 | 91.9 | 1.12 | 0.00000523 | 704 |
| Loss of Function | 1.44 | 11 | 17.5 | 0.629 | 8.29e-7 | 201 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000337 | 0.000337 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000545 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000115 | 0.000114 |
| Middle Eastern | 0.0000545 | 0.0000544 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in mitogenic function of FGF1. May mediate with IER2 FGF-signaling in the establishment of laterality in the embryo (By similarity). {ECO:0000250|UniProtKB:Q6T938, ECO:0000269|PubMed:9806903}.;
- Pathway
- Fibroblast growth factor-1
(Consensus)
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.846
- rvis_EVS
- -0.73
- rvis_percentile_EVS
- 14.02
Haploinsufficiency Scores
- pHI
- 0.0669
- hipred
- N
- hipred_score
- 0.447
- ghis
- 0.602
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.967
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fibp
- Phenotype
Zebrafish Information Network
- Gene name
- fibpb
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- decreased length
Gene ontology
- Biological process
- fibroblast growth factor receptor signaling pathway;platelet aggregation
- Cellular component
- nucleus;mitochondrion;endomembrane system;membrane;nuclear speck
- Molecular function
- fibroblast growth factor binding